Page last updated: 2024-09-04
5-hydroxybendazac and acetaminophen
5-hydroxybendazac has been researched along with acetaminophen in 1 studies
Compound Research Comparison
Studies (5-hydroxybendazac) | Trials (5-hydroxybendazac) | Recent Studies (post-2010) (5-hydroxybendazac) | Studies (acetaminophen) | Trials (acetaminophen) | Recent Studies (post-2010) (acetaminophen) |
---|---|---|---|---|---|
8 | 0 | 0 | 20,696 | 2,848 | 8,242 |
Protein Interaction Comparison
Protein | Taxonomy | 5-hydroxybendazac (IC50) | acetaminophen (IC50) |
---|---|---|---|
Myoglobin | Homo sapiens (human) | 2.3 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bascal, ZA; Wolff, SP; Woollard, AC | 1 |
Other Studies
1 other study(ies) available for 5-hydroxybendazac and acetaminophen
Article | Year |
---|---|
Antioxidant characteristics of some potential anticataract agents. Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract.
Topics: Acetaminophen; Ampyrone; Antioxidants; Aspirin; Biphenyl Compounds; Cataract; Chelating Agents; Erythrocytes; Free Radicals; Hemin; Humans; Hydrazines; Indazoles; Phenol; Phenols; Picrates | 1990 |